Growth Metrics

Precision Biosciences (DTIL) Income towards Parent Company (2018 - 2025)

Historic Income towards Parent Company for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to -$20.0 million.

  • Precision Biosciences' Income towards Parent Company fell 118.37% to -$20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.0 million, marking a year-over-year decrease of 2935479.45%. This contributed to the annual value of -$18.8 million for FY2023, which is 5147.7% up from last year.
  • Precision Biosciences' Income towards Parent Company amounted to -$20.0 million in Q3 2025, which was down 118.37% from -$21.1 million recorded in Q2 2025.
  • Over the past 5 years, Precision Biosciences' Income towards Parent Company peaked at $25.4 million during Q2 2024, and registered a low of -$30.7 million during Q4 2021.
  • In the last 5 years, Precision Biosciences' Income towards Parent Company had a median value of -$11.6 million in 2021 and averaged -$11.3 million.
  • Data for Precision Biosciences' Income towards Parent Company shows a peak YoY increase of 38707.38% (in 2024) and a maximum YoY decrease of 73166.37% (in 2024) over the last 5 years.
  • Quarter analysis of 5 years shows Precision Biosciences' Income towards Parent Company stood at -$30.7 million in 2021, then soared by 70.5% to -$9.1 million in 2022, then skyrocketed by 68.49% to -$2.9 million in 2023, then crashed by 731.66% to -$23.7 million in 2024, then grew by 15.76% to -$20.0 million in 2025.
  • Its last three reported values are -$20.0 million in Q3 2025, -$21.1 million for Q2 2025, and -$21.1 million during Q1 2025.